Bellicum pharmaceuticals to present at the biocentury 23rd annual
newsmakers in the biotech industry conference
Houston--(business wire)--bellicum pharmaceuticals, inc. (nasdaq:blcm), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that tom farrell, president and ceo, will present at the biocentury 23rd annual newsmakers in the biotech industry conference. the presentation will take place on friday, september 9, 2016 at 9:30 a.m. edt in new york city. a live webcast of the presentation may be accessed from the news & events section of the bellicum website. an archived version of the webcast will be available for replay for at least two weeks following the event. about bellicum pharmaceuticals bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. bellicum is using its proprietary chemical induction of dimerization (cid) technology platform to engineer and control components of the immune system. bellicum is developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (hsct), and car t and tcr cell therapies. more information can be found at www.bellicum.com.
BLCM Ratings Summary
BLCM Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission